Jordan Johnson, Founder and Principal at Bridge Oncology and Legal Data Expert, shared a post on LinkedIn:
“Over the next several days, many discussions will focus on percentage increases, reimbursement reductions, and payment tables.
However, reimbursement changes represent only a small part of the broader picture.
The real impact comes from understanding how payment changes intersect with policy updates, 340B proposals, site-neutral payment expansion, workflow redesign, electronic medical record (EMR) structure, coding, compliance, operational efficiency, and total cost of care.
These connections determine whether an organization is able to identify opportunities proactively or is forced to react after changes take effect.
At Bridge Oncology, the focus is on connecting these elements because healthcare transformation is not driven by a single reimbursement figure – it depends on understanding how policy and operational changes affect the entire oncology ecosystem.
This is why more than 10,000 healthcare executives, attorneys, health policy leaders, physicians, administrators, coders, pharmacists, revenue cycle leaders, and compliance professionals subscribe to the Bridge Oncology Newsletter.
They seek more than payment updates – they want a comprehensive understanding of the broader implications for oncology practice and healthcare delivery.
If you have not yet subscribed, now is an opportunity to stay informed.”
Other articles about EMR on OncoDaily.